Follow the Live #NephTrials Discussion on Spironolactone and its Impact on Dialysis Patients: Join on September 28 @ 9 p.m. EST
The #NephTrials initiative is an exciting series of conversations combining expertise from: The ISN-ACT Global Trials Focus The ISN-ACT Toolkit The #NephJC community Join us on September 28, 2021, at 9 p.m. EST to discuss: Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE), evaluating if spironolactone reduces heart failure and heart-related deaths in dialysis patients. — Discussion focus: Run-in periods: useful or threat...